Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZYMEWORKS INC (US)

11.92
+0.0000
Volume:359.89K
Turnover:4.27M
Market Cap:829.36M
PE:-7.37
High:12.08
Open:11.58
Low:11.58
Close:11.92
Loading ...

Landsea Homes, LandBridge, and More Stocks See Action From Activist Investors -- Barrons.com

Dow Jones
·
04 Jan

BUZZ-Zymeworks jumps after JPM upgrades stock to 'overweight'

Reuters
·
16 Dec 2024

JPMorgan Upgrades Zymeworks to Overweight From Neutral, Adjusts Price Target to $18 From $12

MT Newswires Live
·
16 Dec 2024

Zymeworks Inc : Jefferies Raises Target Price to $24 From $22

THOMSON REUTERS
·
16 Dec 2024

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zymeworks (ZYME) and Axsome Therapeutics (AXSM)

TIPRANKS
·
16 Dec 2024

Zymeworks Inc : JP Morgan Raises to Overweight From Neutral; Raises Target Price to $18 From $12

THOMSON REUTERS
·
16 Dec 2024

U.S. RESEARCH ROUNDUP-Amazon, Broadcom, Exxon Mobil

Reuters
·
13 Dec 2024

Zymeworks Advances Oncology and Expands Therapeutic Reach

TIPRANKS
·
12 Dec 2024

PRESS DIGEST-Canada - Nov 22

Reuters
·
22 Nov 2024

Zymeworks Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
22 Nov 2024

Zymeworks Shares up 2.8% After FDA Approves Co, Jazz Pharma's Biliary Tract Cancer Drug

THOMSON REUTERS
·
21 Nov 2024

Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK

Dow Jones
·
21 Nov 2024

Zymeworks Inc : Leerink Partners Raises Target Price to $26 From $25

THOMSON REUTERS
·
21 Nov 2024

Zymeworks to Showcase Innovations at Investor Conferences

TIPRANKS
·
21 Nov 2024

Zymeworks Secures FDA Approval for Ziihera

TIPRANKS
·
21 Nov 2024

Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer

MT Newswires Live
·
21 Nov 2024

Zymeworks Shares up 2.5% Premarket After FDA Approves Co, Jazz Pharma's Biliary Tract Cancer Drug

THOMSON REUTERS
·
21 Nov 2024

FDA Grants U.S. Approval of Ziihera® (Zanidatamab-Hrii) for the Treatment of Adults With Previously Treated, Unresectable or Metastatic Her2-Positive (Ihc 3+) Biliary Tract Cancer (BTC)

THOMSON REUTERS
·
21 Nov 2024

Zymeworks Inc - to Receive $25M Milestone Payment From Jazz Pharmaceuticals

THOMSON REUTERS
·
21 Nov 2024

Zymeworks Shares Rise After Upgrade From Leerink Partners

MT Newswires Live
·
08 Nov 2024